Contact
Please use this form to send email to PR contact of this press release:
New Research at ACC25 Shows Daxor BVA-Identified Euvolemic Heart Failure Patients Experience 2.61 Times Better Survival
TO:
Please use this form to send email to PR contact of this press release:
New Research at ACC25 Shows Daxor BVA-Identified Euvolemic Heart Failure Patients Experience 2.61 Times Better Survival
TO: